VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
WEIGEL, NANCY
One or more keywords matched the following items that are connected to
WEIGEL, NANCY
Item Type
Name
Academic Article
1,25-dihydroxyvitamin D3 modulates phosphorylation of serine 205 in the human vitamin D receptor: site-directed mutagenesis of this residue promotes alternative phosphorylation.
Academic Article
Vector-averaged gravity-induced changes in cell signaling and vitamin D receptor activity in MG-63 cells are reversed by a 1,25-(OH)2D3 analog, EB1089.
Academic Article
Repressors of androgen and progesterone receptor action.
Academic Article
Differential skeletal responses of hindlimb unloaded rats on a vitamin D-deficient diet to 1,25-dihydroxyvitamin D3 and its analog, seocalcitol (EB1089).
Academic Article
Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Academic Article
1{alpha},25-Dihydroxyvitamin D3 inhibits growth of VCaP prostate cancer cells despite inducing the growth-promoting TMPRSS2:ERG gene fusion.
Academic Article
The functional consequences of cross-talk between the vitamin D receptor and ERK signaling pathways are cell-specific.
Academic Article
Prostate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDRE.
Academic Article
Interactions between vitamin D and androgen receptor signaling in prostate cancer cells.
Academic Article
Novel nonsecosteroidal vitamin D receptor modulator inhibits the growth of LNCaP xenograft tumors in athymic mice without increased serum calcium.
Academic Article
Vitamin D and prostate cancer.
Academic Article
Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells.
Academic Article
Vitamin D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cells.
Concept
Receptors, Calcitriol
Academic Article
The prostate cancer TMPRSS2:ERG fusion synergizes with the vitamin D receptor (VDR) to induce CYP24A1 expression-limiting VDR signaling.
Academic Article
Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERG.
Grant
Targets of Vitamin D Receptor Action in Prostate
Grant
REGULATION OF PROGESTERONE RECEPTORS BY PHOSPHORYLATION
Grant
INHIBITION OF PROSTATE CANCER CELL GROWTH BY VITAMIN D
Search Criteria
Receptors Calcitriol